<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-11-01" modified="2020-10-07" version="227">
<accession>P23246</accession>
<accession>P30808</accession>
<accession>Q5SZ71</accession>
<name>SFPQ_HUMAN</name>
<protein>
<recommendedName>
<fullName>Splicing factor, proline- and glutamine-rich</fullName>
</recommendedName>
<alternativeName>
<fullName>100 kDa DNA-pairing protein</fullName>
<shortName>hPOMp100</shortName>
</alternativeName>
<alternativeName>
<fullName>DNA-binding p52/p100 complex, 100 kDa subunit</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="48">Polypyrimidine tract-binding protein-associated-splicing factor</fullName>
<shortName evidence="47">PSF</shortName>
<shortName>PTB-associated-splicing factor</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SFPQ</name>
<name type="synonym">PSF</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Genes Dev." volume="7" first="393" last="406">
<title>Cloning and characterization of PSF, a novel pre-mRNA splicing factor.</title>
<authorList>
<person name="Patton J.G."/>
<person name="Porro E.B."/>
<person name="Galceran J."/>
<person name="Tempst P."/>
<person name="Nadal-Ginard B."/>
</authorList>
<dbReference type="PubMed" id="8449401"/>
<dbReference type="DOI" id="10.1101/gad.7.3.393"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>FUNCTION</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Lilla S."/>
<person name="von Kriegsheim A."/>
<person name="Lempens A."/>
<person name="Kolch W."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 33-44; 218-236; 246-267; 272-286; 299-315; 320-330; 350-358; 364-407; 414-425; 431-462; 480-493; 517-536; 549-559; 567-572; 575-581; 600-606; 612-630 AND 667-695</scope>
<scope>METHYLATION AT LYS-314; ARG-571; ARG-681 AND ARG-693</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1993" name="Biochem. J." volume="290" first="267" last="272">
<title>Purification and characterization of a DNA-binding heterodimer of 52 and 100 kDa from HeLa cells.</title>
<authorList>
<person name="Zhang W.-W."/>
<person name="Zhang L.-X."/>
<person name="Busch R.K."/>
<person name="Farres J."/>
<person name="Busch H."/>
</authorList>
<dbReference type="PubMed" id="8439294"/>
<dbReference type="DOI" id="10.1042/bj2900267"/>
</citation>
<scope>PROTEIN SEQUENCE OF 48-68 AND 213-246</scope>
<scope>BLOCKAGE OF N-TERMINUS</scope>
<scope>DNA-BINDING</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="RNA" volume="3" first="1313" last="1326">
<title>The human U5 snRNP-specific 100-kD protein is an RS domain-containing, putative RNA helicase with significant homology to the yeast splicing factor Prp28p.</title>
<authorList>
<person name="Teigelkamp S."/>
<person name="Mundt C."/>
<person name="Achsel T."/>
<person name="Will C.L."/>
<person name="Luehrmann R."/>
</authorList>
<dbReference type="PubMed" id="9409622"/>
</citation>
<scope>PROTEIN SEQUENCE OF 292-311; 415-421 AND 503-510</scope>
<scope>IDENTIFICATION IN U5/4/6 SNRNP COMPLEXES</scope>
</reference>
<reference key="7">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 299-314 AND 480-493</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1989" name="Development" volume="105" first="723" last="731">
<title>Cloning and characterization of a myoblast cell surface antigen defined by 24.1D5 monoclonal antibody.</title>
<authorList>
<person name="Gower H.J."/>
<person name="Moore S.E."/>
<person name="Dickson G."/>
<person name="Elsom V.L."/>
<person name="Nayak R."/>
<person name="Walsh F.S."/>
</authorList>
<dbReference type="PubMed" id="2480877"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 312-707</scope>
<source>
<tissue>Fetal skeletal muscle</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="RNA" volume="4" first="1493" last="1499">
<title>The snRNP-free U1A (SF-A) complex(es): identification of the largest subunit as PSF, the polypyrimidine-tract binding protein-associated splicing factor.</title>
<authorList>
<person name="Lutz C.S."/>
<person name="Cooke C."/>
<person name="O'Connor J.P."/>
<person name="Kobayashi R."/>
<person name="Alwine J.C."/>
</authorList>
<dbReference type="PubMed" id="9848648"/>
<dbReference type="DOI" id="10.1017/s1355838298981183"/>
</citation>
<scope>PROTEIN SEQUENCE OF 414-421 AND 427-448</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SNRPA</scope>
<scope>IDENTIFICATION IN A SNRNP-FREE COMPLEX WITH SNRPA</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="J. Cell. Biochem." volume="76" first="559" last="566">
<title>Differential nuclear localization and nuclear matrix association of the splicing factors PSF and PTB.</title>
<authorList>
<person name="Meissner M."/>
<person name="Dechat T."/>
<person name="Gerner C."/>
<person name="Grimm R."/>
<person name="Foisner R."/>
<person name="Sauermann G."/>
</authorList>
<dbReference type="PubMed" id="10653975"/>
<dbReference type="DOI" id="10.1002/(sici)1097-4644(20000315)76:4&lt;559::aid-jcb4&gt;3.0.co;2-u"/>
</citation>
<scope>PROTEIN SEQUENCE OF 600-606 AND 667-677</scope>
<scope>INTERACTION WITH PTBP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1994" name="EMBO J." volume="13" first="3356" last="3367">
<title>A novel set of spliceosome-associated proteins and the essential splicing factor PSF bind stably to pre-mRNA prior to catalytic step II of the splicing reaction.</title>
<authorList>
<person name="Gozani O."/>
<person name="Patton J.G."/>
<person name="Reed R."/>
</authorList>
<dbReference type="PubMed" id="8045264"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1994.tb06638.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PRE-MRNA</scope>
<scope>IDENTIFICATION IN SPLICEOSOME COMPLEX</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="2233" last="2239">
<title>Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma.</title>
<authorList>
<person name="Clark J."/>
<person name="Lu Y.-J."/>
<person name="Sidhar S.K."/>
<person name="Parker C."/>
<person name="Gill S."/>
<person name="Smedley D."/>
<person name="Hamoudi R."/>
<person name="Linehan W.M."/>
<person name="Shipley J."/>
<person name="Cooper C.S."/>
</authorList>
<dbReference type="PubMed" id="9393982"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201394"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH TFE3</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="26261" last="26264">
<title>The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a direct interaction.</title>
<authorList>
<person name="Straub T."/>
<person name="Grue P."/>
<person name="Uhse A."/>
<person name="Lisby M."/>
<person name="Knudsen B.R."/>
<person name="Tange T.O."/>
<person name="Westergaard O."/>
<person name="Boege F."/>
</authorList>
<dbReference type="PubMed" id="9756848"/>
<dbReference type="DOI" id="10.1074/jbc.273.41.26261"/>
</citation>
<scope>INTERACTION WITH TOP1</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH NONO AND TOP1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Biochemistry" volume="39" first="7552" last="7558">
<title>PSF/p54(nrb) stimulates 'jumping' of DNA topoisomerase I between separate DNA helices.</title>
<authorList>
<person name="Straub T."/>
<person name="Knudsen B.R."/>
<person name="Boege F."/>
</authorList>
<dbReference type="PubMed" id="10858305"/>
<dbReference type="DOI" id="10.1021/bi992898e"/>
</citation>
<scope>FUNCTION IN DNA UNWINDING</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Mol. Endocrinol." volume="14" first="774" last="782">
<title>Polypyrimidine tract-binding protein-associated splicing factor is a negative regulator of transcriptional activity of the porcine p450scc insulin-like growth factor response element.</title>
<authorList>
<person name="Urban R.J."/>
<person name="Bodenburg Y."/>
<person name="Kurosky A."/>
<person name="Wood T.G."/>
<person name="Gasic S."/>
</authorList>
<dbReference type="PubMed" id="10847580"/>
<dbReference type="DOI" id="10.1210/mend.14.6.0485"/>
</citation>
<scope>FUNCTION IN TRANSCRIPTION REGULATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2000" name="Nucleic Acids Res." volume="28" first="3022" last="3030">
<title>Human 100-kDa homologous DNA-pairing protein is the splicing factor PSF and promotes DNA strand invasion.</title>
<authorList>
<person name="Akhmedov A.T."/>
<person name="Lopez B.S."/>
</authorList>
<dbReference type="PubMed" id="10931916"/>
<dbReference type="DOI" id="10.1093/nar/28.16.3022"/>
</citation>
<scope>FUNCTION IN HOMOLOGOUS DNA PAIRING</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="Cell" volume="106" first="465" last="475">
<title>The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Carmichael G.G."/>
</authorList>
<dbReference type="PubMed" id="11525732"/>
<dbReference type="DOI" id="10.1016/s0092-8674(01)00466-4"/>
</citation>
<scope>FUNCTION IN NUCLEAR RETENTION OF A-TO-I EDITED RNAS</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH NONO AND MATR3</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="Mol. Biol. Cell" volume="12" first="2328" last="2340">
<title>Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions.</title>
<authorList>
<person name="Shav-Tal Y."/>
<person name="Cohen M."/>
<person name="Lapter S."/>
<person name="Dye B."/>
<person name="Patton J.G."/>
<person name="Vandekerckhove J."/>
<person name="Zipori D."/>
</authorList>
<dbReference type="PubMed" id="11514619"/>
<dbReference type="DOI" id="10.1091/mbc.12.8.2328"/>
</citation>
<scope>INTERACTION WITH SNRNP70</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="2298" last="2311">
<title>PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors.</title>
<authorList>
<person name="Mathur M."/>
<person name="Tucker P.W."/>
<person name="Samuels H.H."/>
</authorList>
<dbReference type="PubMed" id="11259580"/>
<dbReference type="DOI" id="10.1128/mcb.21.7.2298-2311.2001"/>
</citation>
<scope>FUNCTION IN TRANSCRIPTION REGULATION</scope>
<scope>INTERACTION WITH RXRA; THRA AND SIN3A</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Endocrinology" volume="143" first="1280" last="1290">
<title>Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription.</title>
<authorList>
<person name="Sewer M.B."/>
<person name="Nguyen V.Q."/>
<person name="Huang C.J."/>
<person name="Tucker P.W."/>
<person name="Kagawa N."/>
<person name="Waterman M.R."/>
</authorList>
<dbReference type="PubMed" id="11897684"/>
<dbReference type="DOI" id="10.1210/endo.143.4.8748"/>
</citation>
<scope>FUNCTION IN TRANSCRIPTION REGULATION</scope>
<scope>INTERACTION WITH NR5A1 AND SIN3A</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH NONO AND NR5A1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="RNA" volume="8" first="1334" last="1347">
<title>PSF and p54nrb bind a conserved stem in U5 snRNA.</title>
<authorList>
<person name="Peng R."/>
<person name="Dye B.T."/>
<person name="Perez I."/>
<person name="Barnard D.C."/>
<person name="Thompson A.B."/>
<person name="Patton J.G."/>
</authorList>
<dbReference type="PubMed" id="12403470"/>
<dbReference type="DOI" id="10.1017/s1355838202022070"/>
</citation>
<scope>INTERACTION WITH NONO AND U5 SNRNA</scope>
<scope>IDENTIFICATION IN U5/4/6 SNRNP AND SPLICEOSOME COMPLEXES</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="Nature" volume="426" first="570" last="574">
<title>Proteomic characterization of the human centrosome by protein correlation profiling.</title>
<authorList>
<person name="Andersen J.S."/>
<person name="Wilkinson C.J."/>
<person name="Mayor T."/>
<person name="Mortensen P."/>
<person name="Nigg E.A."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="14654843"/>
<dbReference type="DOI" id="10.1038/nature02166"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Lymphoblast</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="5205" last="5210">
<title>Identification of the polypyrimidine tract binding protein-associated splicing factor.p54(nrb) complex as a candidate DNA double-strand break rejoining factor.</title>
<authorList>
<person name="Bladen C.L."/>
<person name="Udayakumar D."/>
<person name="Takeda Y."/>
<person name="Dynan W.S."/>
</authorList>
<dbReference type="PubMed" id="15590677"/>
<dbReference type="DOI" id="10.1074/jbc.m412758200"/>
</citation>
<scope>FUNCTION IN DNA REPAIR</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>DNA-BINDING</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="756" last="763">
<title>Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners.</title>
<authorList>
<person name="Wu X."/>
<person name="Yoo Y."/>
<person name="Okuhama N.N."/>
<person name="Tucker P.W."/>
<person name="Liu G."/>
<person name="Guan J.L."/>
</authorList>
<dbReference type="PubMed" id="16767080"/>
<dbReference type="DOI" id="10.1038/ncb1433"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH NONO AND WASL</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="Blood" volume="110" first="2600" last="2609">
<title>NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.</title>
<authorList>
<person name="Galietta A."/>
<person name="Gunby R.H."/>
<person name="Redaelli S."/>
<person name="Stano P."/>
<person name="Carniti C."/>
<person name="Bachi A."/>
<person name="Tucker P.W."/>
<person name="Tartari C.J."/>
<person name="Huang C.J."/>
<person name="Colombo E."/>
<person name="Pulford K."/>
<person name="Puttini M."/>
<person name="Piazza R.G."/>
<person name="Ruchatz H."/>
<person name="Villa A."/>
<person name="Donella-Deana A."/>
<person name="Marin O."/>
<person name="Perrotti D."/>
<person name="Gambacorti-Passerini C."/>
</authorList>
<dbReference type="PubMed" id="17537995"/>
<dbReference type="DOI" id="10.1182/blood-2006-01-028647"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-293</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="57" last="65">
<title>The PSF.p54nrb complex is a novel Mnk substrate that binds the mRNA for tumor necrosis factor alpha.</title>
<authorList>
<person name="Buxade M."/>
<person name="Morrice N."/>
<person name="Krebs D.L."/>
<person name="Proud C.G."/>
</authorList>
<dbReference type="PubMed" id="17965020"/>
<dbReference type="DOI" id="10.1074/jbc.m705286200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-8 AND SER-283 BY MKNK2</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-687</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-273 AND THR-687</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Proteomics" volume="8" first="2907" last="2910">
<title>Proteomic identification of a PSF/p54nrb heterodimer as RNF43 oncoprotein-interacting proteins.</title>
<authorList>
<person name="Miyamoto K."/>
<person name="Sakurai H."/>
<person name="Sugiura T."/>
</authorList>
<dbReference type="PubMed" id="18655028"/>
<dbReference type="DOI" id="10.1002/pmic.200800083"/>
</citation>
<scope>INTERACTION WITH RNF43</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Cell. Signal." volume="21" first="1415" last="1422">
<title>BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest.</title>
<authorList>
<person name="Lukong K.E."/>
<person name="Huot M.E."/>
<person name="Richard S."/>
</authorList>
<dbReference type="PubMed" id="19439179"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2009.04.008"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH PTK6</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-319; LYS-338; LYS-421 AND LYS-472</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Mol. Cell" volume="40" first="126" last="137">
<title>Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing.</title>
<authorList>
<person name="Heyd F."/>
<person name="Lynch K.W."/>
</authorList>
<dbReference type="PubMed" id="20932480"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.09.013"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT THR-687</scope>
<scope>INTERACTION WITH THRAP3</scope>
<scope>MUTAGENESIS OF THR-687</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E10474" last="E10474">
<title>Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins participate in the suppression of macrophage apoptosis.</title>
<authorList>
<person name="Danelishvili L."/>
<person name="Yamazaki Y."/>
<person name="Selker J."/>
<person name="Bermudez L.E."/>
</authorList>
<dbReference type="PubMed" id="20454556"/>
<dbReference type="DOI" id="10.1371/journal.pone.0010474"/>
</citation>
<scope>INTERACTION WITH M.TUBERCULOSIS RV3654C (MICROBIAL INFECTION)</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33 AND SER-626</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Hum. Mol. Genet." volume="20" first="4916" last="4931">
<title>The X-chromosome-linked intellectual disability protein PQBP1 is a component of neuronal RNA granules and regulates the appearance of stress granules.</title>
<authorList>
<person name="Kunde S.A."/>
<person name="Musante L."/>
<person name="Grimme A."/>
<person name="Fischer U."/>
<person name="Mueller E."/>
<person name="Wanker E.E."/>
<person name="Kalscheuer V.M."/>
</authorList>
<dbReference type="PubMed" id="21933836"/>
<dbReference type="DOI" id="10.1093/hmg/ddr430"/>
</citation>
<scope>INTERACTION WITH PQBP1</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33; SER-273 AND SER-283</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33; SER-273; SER-283; THR-368; SER-374; SER-496; SER-626; THR-687 AND TYR-691</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-236; ARG-242; ARG-245; ARG-681; ARG-693 AND ARG-695</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="43">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-338</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-338</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0128558" last="E0128558">
<title>Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.</title>
<authorList>
<person name="Nicolai S."/>
<person name="Filippi S."/>
<person name="Caputo M."/>
<person name="Cipak L."/>
<person name="Gregan J."/>
<person name="Ammerer G."/>
<person name="Frontini M."/>
<person name="Willems D."/>
<person name="Prantera G."/>
<person name="Balajee A.S."/>
<person name="Proietti-De-Santis L."/>
</authorList>
<dbReference type="PubMed" id="26030138"/>
<dbReference type="DOI" id="10.1371/journal.pone.0128558"/>
</citation>
<scope>INTERACTION WITH ERCC6</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2017" name="Mol. Cell" volume="67" first="387" last="399">
<title>HEXIM1 and NEAT1 Long non-coding RNA form a multi-subunit complex that regulates DNA-mediated innate immune response.</title>
<authorList>
<person name="Morchikh M."/>
<person name="Cribier A."/>
<person name="Raffel R."/>
<person name="Amraoui S."/>
<person name="Cau J."/>
<person name="Severac D."/>
<person name="Dubois E."/>
<person name="Schwartz O."/>
<person name="Bennasser Y."/>
<person name="Benkirane M."/>
</authorList>
<dbReference type="PubMed" id="28712728"/>
<dbReference type="DOI" id="10.1016/j.molcel.2017.06.020"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PRKDC; XRCC5; XRCC6; HEXIM1; NONO; PSPC1; RBM14 AND MATR3</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-271; LYS-279 AND LYS-338</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2015" name="Nucleic Acids Res." volume="43" first="3826" last="3840">
<title>The structure of human SFPQ reveals a coiled-coil mediated polymer essential for functional aggregation in gene regulation.</title>
<authorList>
<person name="Lee M."/>
<person name="Sadowska A."/>
<person name="Bekere I."/>
<person name="Ho D."/>
<person name="Gully B.S."/>
<person name="Lu Y."/>
<person name="Iyer K.S."/>
<person name="Trewhella J."/>
<person name="Fox A.H."/>
<person name="Bond C.S."/>
</authorList>
<dbReference type="PubMed" id="25765647"/>
<dbReference type="DOI" id="10.1093/nar/gkv156"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 276-535</scope>
<scope>COILED COIL</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH NONO</scope>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LEU-535; LEU-539; LEU-546 AND MET-549</scope>
</reference>
<comment type="function">
<text evidence="16 20 21 22 23 25 26 28 35 37 39 40 42">DNA- and RNA binding protein, involved in several nuclear processes. Essential pre-mRNA splicing factor required early in spliceosome formation and for splicing catalytic step II, probably as a heteromer with NONO. Binds to pre-mRNA in spliceosome C complex, and specifically binds to intronic polypyrimidine tracts. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45, a phosphorylated form is sequestered by THRAP3 from the pre-mRNA in resting T-cells; T-cell activation and subsequent reduced phosphorylation is proposed to lead to release from THRAP3 allowing binding to pre-mRNA splicing regulatotry elements which represses exon inclusion. Interacts with U5 snRNA, probably by binding to a purine-rich sequence located on the 3' side of U5 snRNA stem 1b. May be involved in a pre-mRNA coupled splicing and polyadenylation process as component of a snRNP-free complex with SNRPA/U1A. The SFPQ-NONO heteromer associated with MATR3 may play a role in nuclear retention of defective RNAs. SFPQ may be involved in homologous DNA pairing; in vitro, promotes the invasion of ssDNA between a duplex DNA and produces a D-loop formation. The SFPQ-NONO heteromer may be involved in DNA unwinding by modulating the function of topoisomerase I/TOP1; in vitro, stimulates dissociation of TOP1 from DNA after cleavage and enhances its jumping between separate DNA helices. The SFPQ-NONO heteromer binds DNA (PubMed:25765647). The SFPQ-NONO heteromer may be involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination and may stabilize paired DNA ends; in vitro, the complex strongly stimulates DNA end joining, binds directly to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to establish a functional preligation complex. SFPQ is involved in transcriptional regulation. Functions as transcriptional activator (PubMed:25765647). Transcriptional repression is mediated by an interaction of SFPQ with SIN3A and subsequent recruitment of histone deacetylases (HDACs). The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity. SFPQ isoform Long binds to the DNA binding domains (DBD) of nuclear hormone receptors, like RXRA and probably THRA, and acts as transcriptional corepressor in absence of hormone ligands. Binds the DNA sequence 5'-CTGAGTC-3' in the insulin-like growth factor response element (IGFRE) and inhibits IGF-I-stimulated transcriptional activity. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation (By similarity). Required for the assembly of nuclear speckles (PubMed:25765647). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728).</text>
</comment>
<comment type="subunit">
<text evidence="16 19 23 24 25 26 27 28 29 32 33 35 36 37 38 40 41 43 44 45">Heterodimer with NONO (PubMed:25765647). Monomer and component of the SFPQ-NONO complex, which is probably a heterotetramer of two 52 kDa (NONO) and two 100 kDa (SFPQ) subunits (PubMed:8439294, PubMed:25765647). The coiled coil domain mediates interaction with NONO, and can also mediate formation of long, linear homooligomers (in vitro) (PubMed:25765647). SFPQ is a component of spliceosome and U5.4/6 snRNP complexes (PubMed:9409622, PubMed:8045264, PubMed:12403470). Interacts with SNRPA/U1A (PubMed:9848648). Component of a snRNP-free complex with SNRPA/U1A (PubMed:9848648). Part of complex consisting of SFPQ, NONO and MATR3 (PubMed:11525732). Interacts with polypyrimidine tract-binding protein 1/PTB (PubMed:10653975). Part of a complex consisting of SFPQ, NONO and NR5A1 (PubMed:11897684). Interacts with RXRA, probably THRA, and SIN3A (PubMed:11259580). Interacts with TOP1 (PubMed:9756848). Part of a complex consisting of SFPQ, NONO and TOP1 (PubMed:9756848). Interacts with SNRNP70 in apoptotic cells (PubMed:11514619). Interacts with PSPC1. Interacts with RNF43 (PubMed:18655028). Interacts with PITX3 and NR4A2/NURR1 (By similarity). Interacts with PTK6 (PubMed:19439179). Interacts with THRAP3; the interaction is dependent on SFPQ phosphorylation at 'Thr-687' and inhibits binding of SFPQ to a ESS1 exonic splicing silencer element-containing RNA (PubMed:20932480). The large PER complex involved in the histone deacetylation is composed of at least HDAC1, PER2, SFPQ and SIN3A. Interacts with PER1 and PER2 (By similarity). Interacts with PQBP1 (PubMed:21933836). Component of a multiprotein complex with NONO and WASL (PubMed:16767080). Interacts with ERCC6 (PubMed:26030138).</text>
</comment>
<comment type="subunit">
<text evidence="34 39">(Microbial infection) Interacts with M.tuberculosis protein Rv3654c, which probably leads to the cleavage of PSF, diminishes the level of caspase-8 in macrophages and suppresses macrophage apoptosis by blocking the extrinsic pathway. Part of the HDP-RNP complex composed of at least HEXIM1, PRKDC, XRCC5, XRCC6, paraspeckle proteins (SFPQ, NONO, PSPC1, RBM14, and MATR3) and NEAT1 RNA.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355453">
<id>P23246</id>
</interactant>
<interactant intactId="EBI-1049011">
<id>P41235</id>
<label>HNF4A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355453">
<id>P23246</id>
</interactant>
<interactant intactId="EBI-350527">
<id>Q15233</id>
<label>NONO</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355453">
<id>P23246</id>
</interactant>
<interactant intactId="EBI-350540">
<id>P26599</id>
<label>PTBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355453">
<id>P23246</id>
</interactant>
<interactant intactId="EBI-1383632">
<id>Q13882</id>
<label>PTK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355453">
<id>P23246</id>
</interactant>
<interactant intactId="EBI-347218">
<id>Q96ST3</id>
<label>SIN3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355453">
<id>P23246</id>
</interactant>
<interactant intactId="EBI-607085">
<id>P09012</id>
<label>SNRPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355453">
<id>P23246</id>
</interactant>
<interactant intactId="EBI-352039">
<id>Q9Y2W1</id>
<label>THRAP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355453">
<id>P23246</id>
</interactant>
<interactant intactId="EBI-1185167">
<id>Q8AZK7</id>
<label>EBNA-LP</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355463">
<id>P23246-1</id>
</interactant>
<interactant intactId="EBI-346715">
<id>P28700</id>
<label>Rxra</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-355463">
<id>P23246-1</id>
</interactant>
<interactant intactId="EBI-286261">
<id>P04625</id>
<label>THRA</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="37">Nucleus speckle</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 33 45">Nucleus matrix</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="33">Cytoplasm</location>
</subcellularLocation>
<text evidence="33">Predominantly in nuclear matrix.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P23246-1</id>
<name>Long</name>
<name>A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P23246-2</id>
<name>Short</name>
<name>F</name>
<sequence type="described" ref="VSP_005855"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="domain">
<text evidence="37">The coiled coil domain mediates interaction with NONO, and can also mediate formation of long, linear homooligomers (in vitro). The coiled coil domain is required for optimal DNA binding, and optimal transcription activation.</text>
</comment>
<comment type="PTM">
<text>The N-terminus is blocked.</text>
</comment>
<comment type="PTM">
<text evidence="22 24 30 31 33 35">Phosphorylated on multiple serine and threonine residues during apoptosis. In vitro phosphorylated by PKC. Phosphorylation stimulates binding to DNA and D-loop formation, but inhibits binding to RNA. Phosphorylation of C-terminal tyrosines promotes its cytoplasmic localization, impaired its binding to polypyrimidine RNA and led to cell cycle arrest. In resting T-cells is phosphorylated at Thr-687 by GSK3B which is proposed to promote association with THRAP and to prevent binding to PTPRC/CD45 pre-mRNA; T-cell activation leads to reduced phosphorylation at Thr-687.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving SFPQ may be a cause of papillary renal cell carcinoma (PRCC). Translocation t(X;1)(p11.2;p34) with TFE3.</text>
</comment>
<comment type="caution">
<text evidence="50">Was originally thought to be myoblast cell surface antigen 24.1D5 and a possible membrane-bound protein ectokinase.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PSFID167.html"/>
</comment>
<dbReference type="EMBL" id="X70944">
<property type="protein sequence ID" value="CAA50283.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL590434">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX07426.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X16850">
<property type="protein sequence ID" value="CAA34747.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS388.1">
<molecule id="P23246-1"/>
</dbReference>
<dbReference type="PIR" id="A46302">
<property type="entry name" value="A46302"/>
</dbReference>
<dbReference type="PIR" id="S29770">
<property type="entry name" value="S29770"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005057.1">
<molecule id="P23246-1"/>
<property type="nucleotide sequence ID" value="NM_005066.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005271169.1">
<molecule id="P23246-1"/>
<property type="nucleotide sequence ID" value="XM_005271112.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005271170.1">
<molecule id="P23246-1"/>
<property type="nucleotide sequence ID" value="XM_005271113.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005271172.1">
<molecule id="P23246-2"/>
<property type="nucleotide sequence ID" value="XM_005271115.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016857542.1">
<molecule id="P23246-1"/>
<property type="nucleotide sequence ID" value="XM_017002053.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016857543.1">
<molecule id="P23246-1"/>
<property type="nucleotide sequence ID" value="XM_017002054.1"/>
</dbReference>
<dbReference type="PDB" id="4WII">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A/B=276-535"/>
</dbReference>
<dbReference type="PDB" id="4WIJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.49"/>
<property type="chains" value="A/B=276-598"/>
</dbReference>
<dbReference type="PDB" id="4WIK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=369-598"/>
</dbReference>
<dbReference type="PDB" id="5WPA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.29"/>
<property type="chains" value="A=276-535"/>
</dbReference>
<dbReference type="PDB" id="6NCQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=276-535"/>
</dbReference>
<dbReference type="PDB" id="6OWJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.94"/>
<property type="chains" value="A/B=276-535"/>
</dbReference>
<dbReference type="PDBsum" id="4WII"/>
<dbReference type="PDBsum" id="4WIJ"/>
<dbReference type="PDBsum" id="4WIK"/>
<dbReference type="PDBsum" id="5WPA"/>
<dbReference type="PDBsum" id="6NCQ"/>
<dbReference type="PDBsum" id="6OWJ"/>
<dbReference type="SASBDB" id="P23246"/>
<dbReference type="SMR" id="P23246"/>
<dbReference type="BioGRID" id="112319">
<property type="interactions" value="341"/>
</dbReference>
<dbReference type="CORUM" id="P23246"/>
<dbReference type="DIP" id="DIP-31272N"/>
<dbReference type="IntAct" id="P23246">
<property type="interactions" value="110"/>
</dbReference>
<dbReference type="MINT" id="P23246"/>
<dbReference type="STRING" id="9606.ENSP00000349748"/>
<dbReference type="DrugBank" id="DB11638">
<property type="generic name" value="Artenimol"/>
</dbReference>
<dbReference type="DrugBank" id="DB09130">
<property type="generic name" value="Copper"/>
</dbReference>
<dbReference type="iPTMnet" id="P23246"/>
<dbReference type="MetOSite" id="P23246"/>
<dbReference type="PhosphoSitePlus" id="P23246"/>
<dbReference type="SwissPalm" id="P23246"/>
<dbReference type="BioMuta" id="SFPQ"/>
<dbReference type="DMDM" id="1709851"/>
<dbReference type="SWISS-2DPAGE" id="P23246"/>
<dbReference type="EPD" id="P23246"/>
<dbReference type="jPOST" id="P23246"/>
<dbReference type="MassIVE" id="P23246"/>
<dbReference type="MaxQB" id="P23246"/>
<dbReference type="PaxDb" id="P23246"/>
<dbReference type="PeptideAtlas" id="P23246"/>
<dbReference type="PRIDE" id="P23246"/>
<dbReference type="ProteomicsDB" id="54073">
<molecule id="P23246-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="54074">
<molecule id="P23246-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="4083">
<property type="antibodies" value="299 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000357214">
<molecule id="P23246-1"/>
<property type="protein sequence ID" value="ENSP00000349748"/>
<property type="gene ID" value="ENSG00000116560"/>
</dbReference>
<dbReference type="GeneID" id="6421"/>
<dbReference type="KEGG" id="hsa:6421"/>
<dbReference type="UCSC" id="uc001bys.4">
<molecule id="P23246-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6421"/>
<dbReference type="DisGeNET" id="6421"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000116560.10"/>
<dbReference type="GeneCards" id="SFPQ"/>
<dbReference type="HGNC" id="HGNC:10774">
<property type="gene designation" value="SFPQ"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000116560">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="SFPQ"/>
<dbReference type="MIM" id="605199">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P23246"/>
<dbReference type="OpenTargets" id="ENSG00000116560"/>
<dbReference type="Orphanet" id="319308">
<property type="disease" value="MiT family translocation renal cell carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA35690"/>
<dbReference type="eggNOG" id="KOG0115">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156221"/>
<dbReference type="HOGENOM" id="CLU_027185_1_0_1"/>
<dbReference type="InParanoid" id="P23246"/>
<dbReference type="KO" id="K13219"/>
<dbReference type="OMA" id="DMRAERF"/>
<dbReference type="OrthoDB" id="1274880at2759"/>
<dbReference type="PhylomeDB" id="P23246"/>
<dbReference type="TreeFam" id="TF315795"/>
<dbReference type="PathwayCommons" id="P23246"/>
<dbReference type="Reactome" id="R-HSA-8849468">
<property type="pathway name" value="PTK6 Regulates Proteins Involved in RNA Processing"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9635465">
<property type="pathway name" value="Suppression of apoptosis"/>
</dbReference>
<dbReference type="SIGNOR" id="P23246"/>
<dbReference type="BioGRID-ORCS" id="6421">
<property type="hits" value="730 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SFPQ">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SFPQ"/>
<dbReference type="GenomeRNAi" id="6421"/>
<dbReference type="Pharos" id="P23246">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P23246"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P23246">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000116560">
<property type="expression patterns" value="Expressed in oviduct epithelium and 245 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P23246">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P23246">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000785">
<property type="term" value="C:chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032839">
<property type="term" value="C:dendrite cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0016363">
<property type="term" value="C:nuclear matrix"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042382">
<property type="term" value="C:paraspeckles"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090575">
<property type="term" value="C:RNA polymerase II transcription regulator complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070888">
<property type="term" value="F:E-box binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003676">
<property type="term" value="F:nucleic acid binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002218">
<property type="term" value="P:activation of innate immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000380">
<property type="term" value="P:alternative mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000724">
<property type="term" value="P:double-strand break repair via homologous recombination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070932">
<property type="term" value="P:histone H3 deacetylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006397">
<property type="term" value="P:mRNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0000398">
<property type="term" value="P:mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042754">
<property type="term" value="P:negative regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902177">
<property type="term" value="P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045876">
<property type="term" value="P:positive regulation of sister chromatid cohesion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042752">
<property type="term" value="P:regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048511">
<property type="term" value="P:rhythmic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008380">
<property type="term" value="P:RNA splicing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="CDD" id="cd12948">
<property type="entry name" value="NOPS_PSF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd12587">
<property type="entry name" value="RRM1_PSF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.70.330">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR012975">
<property type="entry name" value="NOPS"/>
</dbReference>
<dbReference type="InterPro" id="IPR012677">
<property type="entry name" value="Nucleotide-bd_a/b_plait_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR034526">
<property type="entry name" value="PSF_NOPS"/>
</dbReference>
<dbReference type="InterPro" id="IPR034525">
<property type="entry name" value="PSF_RRM1"/>
</dbReference>
<dbReference type="InterPro" id="IPR035979">
<property type="entry name" value="RBD_domain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000504">
<property type="entry name" value="RRM_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF08075">
<property type="entry name" value="NOPS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00076">
<property type="entry name" value="RRM_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00360">
<property type="entry name" value="RRM"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54928">
<property type="entry name" value="SSF54928"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50102">
<property type="entry name" value="RRM"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0233">DNA recombination</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0507">mRNA processing</keyword>
<keyword id="KW-0508">mRNA splicing</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Splicing factor, proline- and glutamine-rich" id="PRO_0000081909">
<location>
<begin position="1"/>
<end position="707"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="9"/>
<end position="11"/>
</location>
</feature>
<feature type="repeat" description="2">
<location>
<begin position="19"/>
<end position="21"/>
</location>
</feature>
<feature type="repeat" description="3">
<location>
<begin position="25"/>
<end position="27"/>
</location>
</feature>
<feature type="domain" description="RRM 1" evidence="18">
<location>
<begin position="297"/>
<end position="369"/>
</location>
</feature>
<feature type="domain" description="RRM 2" evidence="18">
<location>
<begin position="371"/>
<end position="452"/>
</location>
</feature>
<feature type="region of interest" description="3 X 3 AA repeats of R-G-G">
<location>
<begin position="9"/>
<end position="27"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="17 37">
<location>
<begin position="497"/>
<end position="596"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln/Glu/Pro-rich">
<location>
<begin position="10"/>
<end position="266"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="10"/>
<end position="15"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="20"/>
<end position="27"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="56"/>
<end position="65"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="67"/>
<end position="71"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="95"/>
<end position="98"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="99"/>
<end position="103"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="184"/>
<end position="188"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Arg">
<location>
<begin position="571"/>
<end position="574"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="613"/>
<end position="616"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="635"/>
<end position="641"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form SFPQ-TFE3">
<location>
<begin position="662"/>
<end position="663"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MKNK2" evidence="31">
<location>
<position position="8"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="16">
<location>
<position position="9"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="16">
<location>
<position position="9"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10 11">
<location>
<position position="33"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="16">
<location>
<position position="208"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="12">
<location>
<position position="236"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="12">
<location>
<position position="242"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="12">
<location>
<position position="245"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 10 11">
<location>
<position position="273"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MKNK2" evidence="10 11 31">
<location>
<position position="283"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by ALK" evidence="30">
<location>
<position position="293"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine" evidence="46">
<location>
<position position="314"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="319"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="7">
<location>
<position position="338"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="368"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="374"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="379"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="421"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="472"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="496"/>
</location>
</feature>
<feature type="modified residue" description="Dimethylated arginine" evidence="46">
<location>
<position position="571"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 11">
<location>
<position position="626"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="12 46">
<location>
<position position="681"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 6 11 35">
<location>
<position position="687"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="11">
<location>
<position position="691"/>
</location>
</feature>
<feature type="modified residue" description="Dimethylated arginine; alternate" evidence="46">
<location>
<position position="693"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="12">
<location>
<position position="693"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="12">
<location>
<position position="695"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="15">
<location>
<position position="271"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="15">
<location>
<position position="279"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="13 14 15">
<location>
<position position="338"/>
</location>
</feature>
<feature type="splice variant" description="In isoform Short." id="VSP_005855" evidence="49">
<original>RTERFGQGGAGPVGGQGPRGMGPGTPAGYGRGREEYEGPNKKPRF</original>
<variation>VRMIDVG</variation>
<location>
<begin position="663"/>
<end position="707"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding and ability to mediate transcriptional activation; when associated with A-539; A-546 and A-549." evidence="37">
<original>L</original>
<variation>A</variation>
<location>
<position position="535"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding and ability to mediate transcriptional activation; when associated with A-535; A-546 and A-549." evidence="37">
<original>L</original>
<variation>A</variation>
<location>
<position position="539"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding and ability to mediate transcriptional activation; when associated with A-535; A-539 and A-549." evidence="37">
<original>L</original>
<variation>A</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding and ability to mediate transcriptional activation; when associated with A-535; A-539 and A-546." evidence="37">
<original>M</original>
<variation>A</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by GSK3B. Impairs interaction with THRAP3." evidence="35">
<original>T</original>
<variation>A</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with THRAP3 (phosphomimetic)." evidence="35">
<original>T</original>
<variation>D</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AA sequence." ref="5" evidence="49">
<original>G</original>
<variation>R</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="282"/>
<end position="285"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="288"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="298"/>
<end position="303"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="310"/>
<end position="316"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="317"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="326"/>
<end position="329"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="330"/>
<end position="333"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="334"/>
<end position="338"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="342"/>
<end position="352"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="356"/>
<end position="361"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="363"/>
<end position="366"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="370"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="384"/>
<end position="391"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="392"/>
<end position="394"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="397"/>
<end position="404"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="406"/>
<end position="408"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="410"/>
<end position="420"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="421"/>
<end position="433"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="439"/>
<end position="441"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="446"/>
<end position="449"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="455"/>
<end position="457"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="461"/>
<end position="464"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="467"/>
<end position="469"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="470"/>
<end position="474"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="478"/>
<end position="480"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="486"/>
<end position="533"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="555"/>
<end position="588"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WII"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WIJ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NCQ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6OWJ"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8VIJ6"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255"/>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00176"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10653975"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10847580"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10858305"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10931916"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11259580"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11514619"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11525732"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11897684"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12403470"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15590677"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16767080"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17537995"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17965020"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18655028"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19439179"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20454556"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20932480"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21933836"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25765647"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26030138"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28712728"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8045264"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8439294"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8449401"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9409622"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9756848"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9848648"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="47" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8449401"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9848648"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000305"/>
<evidence key="50" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="2480877"/>
</source>
</evidence>
<sequence length="707" mass="76149" checksum="6D8D5EA95E235847" modified="1996-10-01" version="2">MSRDRFRSRGGGGGGFHRRGGGGGRGGLHDFRSPPPGMGLNQNRGPMGPGPGQSGPKPPIPPPPPHQQQQQPPPQQPPPQQPPPHQPPPHPQPHQQQQPPPPPQDSSKPVVAQGPGPAPGVGSAPPASSSAPPATPPTSGAPPGSGPGPTPTPPPAVTSAPPGAPPPTPPSSGVPTTPPQAGGPPPPPAAVPGPGPGPKQGPGPGGPKGGKMPGGPKPGGGPGLSTPGGHPKPPHRGGGEPRGGRQHHPPYHQQHHQGPPPGGPGGRSEEKISDSEGFKANLSLLRRPGEKTYTQRCRLFVGNLPADITEDEFKRLFAKYGEPGEVFINKGKGFGFIKLESRALAEIAKAELDDTPMRGRQLRVRFATHAAALSVRNLSPYVSNELLEEAFSQFGPIERAVVIVDDRGRSTGKGIVEFASKPAARKAFERCSEGVFLLTTTPRPVIVEPLEQLDDEDGLPEKLAQKNPMYQKERETPPRFAQHGTFEYEYSQRWKSLDEMEKQQREQVEKNMKDAKDKLESEMEDAYHEHQANLLRQDLMRRQEELRRMEELHNQEMQKRKEMQLRQEEERRRREEEMMIRQREMEEQMRRQREESYSRMGYMDPRERDMRMGGGGAMNMGDPYGSGGQKFPPLGGGGGIGYEANPGVPPATMSGSMMGSDMRTERFGQGGAGPVGGQGPRGMGPGTPAGYGRGREEYEGPNKKPRF</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

